Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. - Wikidata - wikimedia - TriplyDB

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

http://www.wikidata.org/entity/Q34393174

about

Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy The role of inorganic pyrophosphate in aortic valve calcification.Skeletal effects of zoledronic acid in an animal model of chronic kidney disease Role of TGF-β in a mouse model of high turnover renal osteodystrophy.The bone-vascular axis in chronic kidney disease.Vascular calcification is dependent on plasma levels of pyrophosphate.Effect of medial calcification on vascular function in uremia.Recent progress in the treatment of vascular calcification.Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.The epidemiology of distal radius fractures.Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.Mechanisms and clinical consequences of vascular calcification High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women.Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.Role of Vitamin D in Uremic Vascular Calcification.Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease.Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy.Treatment with pyrophosphate inhibits uremic vascular calcification.Clinical imaging of vascular disease in chronic kidney disease.Zooming in on the genesis of atherosclerotic plaque microcalcifications.What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease.Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.The chemistry of thiosulfate and vascular calcification.A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy.Pro: cardiovascular calcifications are clinically relevant.The leading edge of vascular calcification Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies.Rats with adenine-induced chronic renal failure develop low-renin, salt-sensitive hypertension and increased aortic stiffness.Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification.The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.Exploiting novel valve interstitial cell lines to study calcific aortic valve disease.

P2860

Q27002431-329DC85B-713A-41C4-93C0-7CFB0A6A0886 Q27343503-FA3C5452-823B-4EEC-82E4-ABFD76AB9D48 Q33775764-9DDAED92-4060-416F-9EC3-FA2E87A3BA74 Q33779709-DE14D74C-7E35-4B59-BB1E-A6D389E514B9 Q33827652-97DBD25D-7CF4-4673-9E0C-AF92F17CB66D Q34402808-DBBEB85A-A56D-429E-9ECC-74B11972CA89 Q35021536-82CDA830-3126-4A82-9A3B-50C80E2A9660 Q35086956-D66166D9-E67E-45DE-BFE4-E00A8431CC9D Q35247898-715DAC35-4180-4439-A9C3-4E5BE60E399E Q35309274-4786746E-F01B-443C-9119-CFCED8D6BAE5 Q35525230-E6DD1E68-A834-43E7-8F16-469BF93184D1 Q35936280-ECDDD640-B927-42B3-9137-23A471F6FED3 Q36104700-1059D9C9-F271-4D1D-B0FC-0A0324114B86 Q36142207-0A40444C-E25D-4A88-A2D1-9F63A021EB51 Q36516021-C900CBD6-15D9-4084-A170-846A980EA5A6 Q36860151-D1EBBB0A-DB5C-424D-82F3-09EC02723D6A Q37195354-195C8068-6E7F-4391-B970-72275D029596 Q37522423-343C7A49-B51F-4E08-855A-BE9875024B4C Q37614180-FAEC16EB-6866-450F-9A27-BC8CAC1B1E55 Q37622392-ED150FF6-1639-4305-99E0-3892D73B9EE9 Q37670797-0B02A798-00BD-4CD9-BFAC-C84FA6C94F80 Q37832414-04116EB1-D29D-442F-A14C-808E99CDCE2F Q38458773-95CC878D-ADAD-4484-8EA4-09BED4ED1FEE Q38543758-A0DDD222-91A4-4229-AF51-BD12EB395C8E Q38599585-8F1188CD-E960-4FDC-A31D-B7609E66D5E1 Q38742857-9D1C1A0B-0442-453B-9433-11F8822D51B3 Q38796978-78A79D5C-AD79-4CE6-9F59-FF70370EF336 Q38825566-9C7A7CAE-901E-47CE-863F-31A10B518464 Q39255870-F67EF0F2-11CD-4D9E-91B8-139501FE63E2 Q40963269-33CC9E5F-4B10-4007-A5AB-A2B2B91BF041 Q41191725-CABE279D-43B6-4A58-BBC7-25DA48564107 Q41277036-E0747FEF-4AE4-44BF-825F-0CA891A2E8E0 Q41354300-E5DC381D-32E7-4968-99A4-61EB8C915277 Q42581074-5FC61AC4-7D44-412F-BB54-4009E109C082 Q43437513-34D790FE-8053-4055-9A4C-6FF0BAFAFE45 Q44657342-5CE09439-1F28-4349-B809-D76D687B2E4F Q45001125-3C664751-3A2F-4CF7-9961-D546CD1B66BB Q45932492-5CE17902-C2F7-4728-80C8-75483463F89A Q46293116-8486D0E5-FE6A-4D36-9F8C-D8E3D131E039 Q47328723-D7C18D7C-FD88-4DF4-896D-51449B85AB79

P2860

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

http://www.wikidata.org/entity/Q34393174

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effect of bisphosphonates on v ...... in experimental renal failure.

@ast

Effect of bisphosphonates on v ...... in experimental renal failure.

@en

Effect of bisphosphonates on v ...... in experimental renal failure.

@nl

type

label

Effect of bisphosphonates on v ...... in experimental renal failure.

@ast

Effect of bisphosphonates on v ...... in experimental renal failure.

@en

Effect of bisphosphonates on v ...... in experimental renal failure.

@nl

prefLabel

Effect of bisphosphonates on v ...... in experimental renal failure.

@ast

Effect of bisphosphonates on v ...... in experimental renal failure.

@en

Effect of bisphosphonates on v ...... in experimental renal failure.

@nl

P1433

Q34393174-57186958-DD40-4E42-B494-F60FE5C2AC5F

P1476

Q34393174-7389E4E4-9C26-42D3-AAF1-AFF15AF9879C

P2093

Q34393174-0E27B5DE-43CC-4912-9AB6-029C0BB12B04

Q34393174-221B99C0-316C-4DC7-A985-8DAC5E6ABA5E

Q34393174-3AC433E8-E8FF-46C0-8AF2-9F5622D191DA

Q34393174-8A957B44-3AE5-4E6C-9634-3B7C18160508

Q34393174-9D5E7E5D-445C-4AF6-998B-05C2BACC3952

P2860

Q34393174-059CDAF7-C076-4F99-83CA-51389E8D2CE6

Q34393174-08F9D555-8859-498C-804C-363B1F325769

Q34393174-1E6AD127-B0F4-4285-8AD8-906D86C58B11

Q34393174-42D9FE79-BABF-4C41-99EE-383A5E4F0F6A

Q34393174-58234D26-C0A6-4B42-B7DA-BC20434F700A

Q34393174-6573C38A-8DBF-47BD-9B1D-2E7D559F7EB6

Q34393174-6E81F91C-1603-42C3-821E-18C0E79BEAB2

Q34393174-6FF18383-2891-4B52-B285-AC89A45D249C

Q34393174-70DF15B8-23C5-4A18-BBA6-9B4A221897C9

Q34393174-7233A1D5-4EF6-4192-A826-0EEAD936B5C3

P2888

Q34393174-42995498-9E59-4BE4-AB5D-55905E551A20

P304

Q34393174-A65A8A4D-4A52-4831-AFFF-963E9BCE173C

P31

Q34393174-1FC31C74-8CEA-4FAD-A8B2-DF127BAD43E1

P356

Q34393174-F8B308F5-F99F-48F5-8A13-0C97DB4F7B60

P407

Q34393174-7F685F34-27CC-42FC-9BDB-867E21884391

P433

Q34393174-ADF7D355-B78D-40F5-B254-C2908111CDE3

P478

Q34393174-7CC49A85-30FC-42D9-AE84-1A379EA0AAC4

P577

Q34393174-AC5504D2-591A-4744-AFCA-27E03ED4C27D

P5875

Q34393174-2DCA56BB-B0EC-41C1-86AF-2BE4515A8645

P6179

Q34393174-BD5CA6C5-ECAE-4EF8-B330-BF26C2D96F8C

P698

Q34393174-69BAC3CA-CAD8-40D4-9341-2D86D2273C0D

P932

Q34393174-9022DA40-C413-46A5-8790-B8153540F5A9

P356

P1433

Kidney International

P1476

Effect of bisphosphonates on v ...... in experimental renal failure.

@en

P2093

Hartmut H Malluche

http://www.w3.org/2001/XMLSchema#string

Koba A Lomashvili

http://www.w3.org/2001/XMLSchema#string

Marie-Claude Monier-Faugere

http://www.w3.org/2001/XMLSchema#string

W Charles O'Neill

http://www.w3.org/2001/XMLSchema#string

Xiaonan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification

Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase)

A robotics-based automated assay for inorganic and organic phosphates.

Ecto-enzymes: physiology meets pathology.

Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Pathophysiology of vascular calcification in chronic kidney disease.

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.

A new semiautomatic method for quantitative static and dynamic bone histology.

P2888

P304

617-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2008.646

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23764595

http://www.w3.org/2001/XMLSchema#string

P6179

1004397464

http://www.w3.org/2001/XMLSchema#string

P698

19129793

http://www.w3.org/2001/XMLSchema#string

P932

2999577

http://www.w3.org/2001/XMLSchema#string